Prevalence of hypotension in hypertensive treated patients within the Primary Care setting. The PRESCAP 2010 study

  1. J.A. Divisón-Garrote 5
  2. M.Á. Prieto-Díaz 1
  3. F.J. Alonso-Moreno 2
  4. S.M. Velilla-Zancada 3
  5. C. Escobar-Cervantes 4
  6. J.L. Llisterri-Caro 6
  7. S. Cinza-Sanjurjo 7
  8. G.C. Rodríguez-Roca 8
  9. J. Polo-García 9
  10. V. Pallarés-Carratalá 10
  1. 1 Centro de Salud Vallobín-La Florida, Oviedo, Spain
  2. 2 Centro de Salud Sillería, Toledo, España
  3. 3 Centro de Salud de Nájera, La Rioja, España
  4. 4 Hospital Universitario La Paz, Madrid, España
  5. 5 Centro de Salud Casas Ibañez, Albacete, Spain
  6. 6 Centro de Salud Ingeniero Joaquín Benlloch, Valencia, España
  7. 7 Centro de Salud Porto do Son, A Coruña, España
  8. 8 Centro de Salud Puebla de Montalbán, Toledo, España
  9. 9 Centro de Salud Centro de Salud Casar de Cáceres, Cáceres, España
  10. 10 Universitat Jaume I, Castellón, España
Mostrar afiliacións +
Revista:
Semergen: revista española de medicina de familia

ISSN: 1138-3593

Ano de publicación: 2020

Número: 2

Páxinas: 107-114

Tipo: Artigo

DOI: 10.1016/J.SEMERG.2019.07.003 DIALNET GOOGLE SCHOLAR

Outras publicacións en: Semergen: revista española de medicina de familia

Obxectivos de Desenvolvemento Sustentable

Resumo

Objetivo Determinar la prevalencia de hipotensión y los factores asociados en pacientes hipertensos tratados en atención primaria. Material y métodos Estudio transversal, descriptivo y multicéntrico; 2.635 médicos generales incluyeron consecutivamente a 12.961 pacientes hipertensos tratados y atendidos en atención primaria en España. Fueron analizados: edad, sexo, peso, altura, índice de masa corporal, perímetro de cintura, factores de riesgo cardiovascular (diabetes, dislipidemia, tabaquismo, obesidad, sedentarismo), glucemia en ayunas, perfil de lípidos, así como la presencia de daño en órgano diana (hipertrofia ventricular, microalbuminuria, aterosclerosis carotídea) y enfermedades clínicas asociadas. La hipotensión se definió como presión arterial sistólica inferior a 110 mmHg o presión arterial diastólica inferior a 70 mmHg. Se realizó un análisis multivariante para determinar las variables asociadas a la presencia de hipotensión. Resultados La edad media fue de 66,2 años, un 51,7% de los pacientes eran mujeres. La antigüedad de la hipertensión fue de 9,1 años. Un 13,1% de los pacientes (intervalo de confianza del 95%: 12,4-13,6%) tenían hipotensión, de los cuales el 95% era presión arterial diastólica baja. La prevalencia de hipotensión fue mayor en pacientes de edad avanzada (25,7%) y en individuos con enfermedad coronaria (22,6%). Las variables asociadas con la presencia de hipotensión incluyeron los antecedentes de enfermedad cardiovascular, pacientes tratados con al menos 3 fármacos antihipertensivos, diabetes y edad. Conclusiones Uno de cada 4-5 pacientes de edad avanzada o con enfermedad cardiovascular tenía hipotensión. Los médicos generales deben identificar a estos pacientes para determinar las causas y ajustar el tratamiento para evitar complicaciones.

Referencias bibliográficas

  • E. Rapsomaniki, A. Timmis, J. George, M. Pujades-Rodriguez, A.D. Shah, S. Denaxas, et al. Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1.25 million people Lancet, 383 (2014), pp. 1899-1911 ArticleDownload PDFView Record in ScopusGoogle Scholar
  • C. Thomopoulos, G. Parati, A. Zanchetti Effects of blood pressure lowering on outcome incidence in hypertension: 3. Effects in patients at different levels of cardiovascular risk – overview and meta-analyses of randomized trials J Hypertens, 32 (2014), pp. 2305-2314 View Record in ScopusGoogle Scholar
  • G. Mancia, G. De Backer, A. Dominiczak, R. Cifkova, R. Fagard, G. Germano, et al., Management of Arterial Hypertension of the European Society of Hypertension; European Society of Cardiology 2007 Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) J Hypertens, 25 (2007), pp. 1105-1187 View Record in ScopusGoogle Scholar
  • G. Mancia, S. Laurent, E. Agabiti-Rosei, E. Ambrosioni, M. Burnier, M.J. Caulfield, et al., European Society of Hypertension Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document J Hypertens, 27 (2009), pp. 2121-2158 CrossRefView Record in ScopusGoogle Scholar
  • G. Mancia, R. Fagard, K. Narkiewicz, J. Redon, A. Zanchetti, M. Böhm, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) Eur Heart J, 34 (2013), pp. 2159-2219 View Record in ScopusGoogle Scholar
  • P.A. James, S. Oparil, B.L. Carter, W.C. Cushman, C. Dennison-Himmelfarb, J. Handler, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8) JAMA, 311 (2014), pp. 507-520 CrossRefView Record in ScopusGoogle Scholar
  • P.K. Whelton, R.M. Carey, W.S. Aronow, D.E. Casey Jr., K.J. Collins, C. Dennison Himmelfarb, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines J Am Coll Cardiol, 71 (2018), pp. 2199-2269 ArticleDownload PDFView Record in ScopusGoogle Scholar
  • B. Williams, G. Mancia, W. Spiering, E.A. Rosei, M. Azizi, M. Burnier, et al., ESC Scientific Document Group 2018 ESC/ESH Guidelines for the management of arterial hypertension Eur Heart J, 39 (2018), pp. 3021-3104 CrossRefView Record in ScopusGoogle Scholar
  • S. Bangalore, S. Kumar, A. Volodarskiy, F.H. Messerli Blood pressure targets in patients with coronary artery disease: observations from traditional and Bayesian random effects meta-analysis of randomised trials Heart, 99 (2013), pp. 601-613 CrossRefView Record in ScopusGoogle Scholar
  • X. Xie, E. Atkins, J. Lv, A. Bennett, B. Neal, T. Ninomiya, et al. Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis Lancet, 387 (2016), pp. 435-443 ArticleDownload PDFView Record in ScopusGoogle Scholar
  • The SPRINT Research group, J.T. Wright Jr., J.D. Williamson, P.K. Whelton, J.K. Snyder, K.M. Sink, et al. A randomized trial of intensive versus standard blood pressure control NEJM, 373 (2015), pp. 2103-2116 Google Scholar
  • M. Banach, W.S. Aronow Blood pressure j-curve: current concepts Curr Hypertens Rep, 14 (2012), pp. 556-566 CrossRefView Record in ScopusGoogle Scholar
  • E.P. Tsika, L.E. Poulimenos, K.D. Boudoulas, A.J. Manolis The J-curve in arterial hypertension: fact or fallacy? Cardiology, 129 (2014), pp. 126-135 CrossRefView Record in ScopusGoogle Scholar
  • J.A. Dorresteijn, Y. van der Graaf, W. Spiering, D.E. Grobbee, M.L. Bots, F.L. Visseren, et al., Secondary Manifestations of Arterial Disease Study Group Relation between blood pressure and vascular events and mortality in patients with manifest vascular disease: J-curve revisited Hypertension, 59 (2012), pp. 14-21 View Record in ScopusGoogle Scholar
  • C.J. Pepine, E.M. Handberg, R.M. Cooper-DeHoff, R.G. Marks, P. Kowey, F.H. Messerli, et al., INVEST Investigators A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial JAMA, 290 (2003), pp. 2805-2816 View Record in ScopusGoogle Scholar
  • S. Bangalore, F.H. Messerli, C.C. Wun, A.L. Zuckerman, D. DeMicco, J.B. Kostis, et al., Treating to New Targets Steering Committee and Investigators J-curve revisited: an analysis of blood pressure and cardiovascular events in the Treating to New Targets (TNT) Trial Eur Heart J, 31 (2010), pp. 2897-2908 CrossRefView Record in ScopusGoogle Scholar
  • S. Bangalore, J. Qin, S. Sloan, S.A. Murphy, C.P. Cannon, PROVE IT-TIMI 22 trial investigators What is the optimal blood pressure in patients after acute coronary syndromes? Relationship of blood pressure and cardiovascular events in the PRavastatin OR atorVastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction (PROVE IT-TIMI) 22 trial Circulation, 122 (2010), pp. 2142-2151 View Record in ScopusGoogle Scholar
  • P. Verdecchia, G. Reboldi, F. Angeli, B. Trimarco, G. Mancia, J. Pogue, et al. Systolic and diastolic blood pressure changes in relation with myocardial infarction and stroke in patients with coronary artery disease Hypertension, 65 (2015), pp. 108-114 View Record in ScopusGoogle Scholar
  • E.P. Vamos, M. Harris, C. Millett, U.J. Pape, K. Khunti, V. Curcin, et al. Association of systolic and diastolic blood pressure and all cause mortality in people with newly diagnosed type 2 diabetes: retrospective cohort study BMJ, 345 (2012), p. e5567 CrossRefGoogle Scholar
  • M.S. Tanna, S. Bangalore Antihypertensive therapy and the J-curve: fact or fiction? Curr Hypertens Rep, 17 (2015), p. 6 Google Scholar
  • S. Yusuf, K.K. Teo, J. Pogue, L. Dyal, I. Copland, H. Schumacher, et al., ONTARGET investigators Telmisartan, ramipril, or both in patients at high risk for vascular events N Engl J Med, 358 (2008), pp. 1547-1559 View Record in ScopusGoogle Scholar
  • G. Mancia, H. Schumacher, J. Redon, P. Verdecchia, R. Schmieder, G. Jennings, et al. Blood pressure targets recommended by guidelines and incidence of cardiovascular and renal events in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial (ONTARGET) Circulation, 124 (2011), pp. 1727-1736 View Record in ScopusGoogle Scholar
  • W.C. Cushman, G.W. Evans, R.P. Byington, D.C. Goff Jr., R.H. Grimm Jr., J.A. Cutler, et al., ACCORD Study Group Effects of intensive blood-pressure control in type 2 diabetes mellitus N Engl J Med, 362 (2010), pp. 1575-1585 View Record in ScopusGoogle Scholar
  • P. Verdecchia, J.A. Staessen, F. Angeli, G. de Simone, A. Achilli, A. Ganau, et al., Cardio-Sis investigators Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): an open-label randomised trial Lancet, 374 (2009), pp. 525-533 ArticleDownload PDFView Record in ScopusGoogle Scholar
  • W. Xu, S.I. Goldberg, M. Shubina, A. Turchin Optimal systolic blood pressure target, time to intensification, and time to follow-up in treatment of hypertension: population based retrospective cohort study BMJ, 350 (2015), p. h158 CrossRefGoogle Scholar
  • J.L. Llisterri Caro, G.C. Rodríguez Roca, F.J. Alonso Moreno, M.A. Prieto Díaz, J.R. Banegas Banegas, D. Gonzalez-Segura Alsina, et al., on behalf of the Working Group of Arterial Hypertension of the Spanish Society of Primary Care Physicians (Group HTA/SEMERGEN); and the PRESCAP 2010 investigators Blood pressure control in hypertensive Spanish population attended in primary care setting. The PRESCAP 2010 study Med Clin (Barc), 139 (2012), pp. 653-661 ArticleDownload PDFView Record in ScopusGoogle Scholar
  • A. Patel, S. MacMahon, J. Chalmers, B. Neal, M. Woodward, L. Billot, et al., ADVANCE Collaborative Group Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial Lancet, 370 (2007), pp. 829-840 ArticleDownload PDFView Record in ScopusGoogle Scholar
  • K. Jamerson, M.A. Weber, G.L. Bakris, B. Dahlöf, B. Pitt, V. Shi, et al., ACCOMPLISH Trial Investigators Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients N Engl J Med, 359 (2008), pp. 2417-2428 CrossRefView Record in ScopusGoogle Scholar
  • P. Sleight, J. Redon, P. Verdecchia, G. Mancia, P. Gao, R. Fagard, et al., ONTARGET investigators Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial study J Hypertens, 27 (2009), pp. 1360-1369 View Record in ScopusGoogle Scholar
  • A.D. Protogerou, M.E. Safar, P. Iaria, H. Safar, K. Le Dudal, J. Filipovsky, et al. Diastolic blood pressure and mortality in the elderly with cardiovascular disease Hypertension, 50 (2007), pp. 172-180 View Record in ScopusGoogle Scholar
  • L. Molander, H. Lövheim, T. Norman, P. Nordström, Y. Gustafson Lower systolic blood pressure is associated with greater mortality in people aged 85 and older J Am Geriatr Soc, 56 (2008), pp. 1853-1859 CrossRefView Record in ScopusGoogle Scholar
  • T. Yamazaki, T. Kohro, M. Chujo, M. Ishigaki, T. Hashimoto The occurrence rate of cerebrovascular and cardiac events in patients receiving antihypertensive therapy from the post-marketing surveillance data for valsartan in Japan (J-VALID) Hypertens Res, 36 (2013), pp. 140-150 CrossRefView Record in ScopusGoogle Scholar
  • O. Iritani, Y. Koizumi, Y. Hamazaki, H. Yano, T. Morita, T. Himeno, et al. Association between blood pressure and disability-free survival among community-dwelling elderly patients receiving antihypertensive treatment Hypertens Res, 37 (2014), pp. 772-778 CrossRefView Record in ScopusGoogle Scholar
  • J. Sundström, R. Sheikhi, C.J. Ostgren, B. Svennblad, J. Bodegård, P.M. Nilsson, et al. Blood pressure levels and risk of cardiovascular events and mortality in type-2 diabetes: cohort study of 34 009 primary care patients J Hypertens, 31 (2013), pp. 1603-1610 View Record in ScopusGoogle Scholar
  • C.P. Kovesdy, A.J. Bleyer, M.Z. Molnar, J.Z. Ma, J.J. Sim, W.C. Cushman, et al. Blood pressure and mortality in U.S. veterans with chronic kidney disease: a cohort study Ann Intern Med, 159 (2013), pp. 233-242 CrossRefView Record in ScopusGoogle Scholar
  • PROGRESS Collaborative Group Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack Lancet, 358 (2001), pp. 1033-1041 Google Scholar
  • C.L. White, J.M. Szychowski, P.E. Pergola, T.S. Field, R. Talbert, H. Lau, et al., Secondary Prevention of Small Subcortical Strokes Study Investigators Can blood pressure be lowered safely in older adults with lacunar stroke? The Secondary Prevention of Small Subcortical Strokes study experience J Am Geriatr Soc, 63 (2015), pp. 722-729 CrossRefView Record in ScopusGoogle Scholar
  • A. Gutiérrez-Misis, M.T. Sánchez-Santos, J.R. Banegas, M.V. Castell, J.I. González-Montalvo, A. Otero Walking speed and high blood pressure mortality risk in a Spanish elderly population J Hum Hypertens, 29 (2015), pp. 566-572 CrossRefView Record in ScopusGoogle Scholar
Fonte de datos: Dialnet